Recent advances in obstructive sleep apnoea (OSA) pathophysiology and translational
research have opened new lines of investigation for OSA treatment and management. Key …

Continuous positive airway pressure (CPAP) is the preferred therapy in patients with
obstructive sleep apnea (OSA). However, data suggests treatment adherence is low. In …

Background Randomized controlled trials have failed to demonstrate an effect of CPAP
therapy on mortality. However, these studies have a number of important limitations …

Rationale: Current therapies for obstructive sleep apnea (OSA) are limited by insufficient
efficacy, compliance, or tolerability. An effective pharmacological treatment for OSA is …

Rationale: The co-occurrence of obstructive sleep apnea and chronic obstructive pulmonary
disease, termed overlap syndrome, has a poor prognosis. However, data on positive airway …

Excessive daytime sleepiness (EDS) is a major symptom of obstructive sleep apnoea (OSA),
defined as the inability to stay awake during the day. Its clinical descriptors remain elusive …

Continuous positive airway pressure (CPAP) has been the standard treatment of obstructive
sleep apnoea/hypopnoea syndrome (OSA) for almost four decades. Though usually …

Study Objectives: There is a complex interplay between obstructive sleep apnea (OSA) and
type 2 diabetes. There are minimal data regarding the effects of treating OSA with positive …

Continuous positive airway pressure (CPAP) telemonitoring (TMg) has become widely
implemented in routine clinical care. Objective measures of CPAP compliance, residual …

Introduction Continuous positive airway pressure (CPAP) is the first-line therapy for
obstructive sleep apnea (OSA). CPAP is highly effective for improving symptoms and quality …